November 20, 2025, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, is excited to announce the hiring of Steven Gossert, Ph.D. as Applications Scientist, Computational Drug Design. Over the last several years, Steven has worked as a postdoctoral modeling scientist in Drug Product Development at [...]

FOR IMMEDIATE RELEASE Baltimore, MD — October 23, 2025 — SilcsBio, a leader in physics-based computational drug design, is proud to announce the launch of the SilcsBio Software - Covalent Suite, an innovative addition to its expanding portfolio of drug discovery solutions. Designed to accelerate the discovery of targeted covalent inhibitors (TCIs), the Covalent Suite empowers [...]